Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Multiple targets via adaptogenic modulation of stress response pathways" does not refer to a single molecular target, receptor, enzyme or protein. Instead it describes the broad mechanism by which adaptogens—natural compounds typically derived from certain medicinal plants—exert their effects. Adaptogens do this by modulating numerous molecular targets across several canonical cellular signaling networks involved in the body's adaptation to physical and psychological stressors. These mechanisms include upregulation or downregulation of gene expression related to neurohormones (e.g., CRH), GPCRs (e.g., TLR9), nuclear receptors (e.g., RORA), kinases (MAPKs), phosphatases (PTPRD/PTPRR), metabolic enzymes and chaperones. The net effect is enhanced resilience through improved homeostatic control over immune function, neuroendocrine activity and cellular metabolism[1][2][3]. Because this entry refers collectively to many different molecules rather than one defined target structure with a unique name or abbreviation—and because it cannot be mapped onto any single canonical drug target—it is not considered a valid therapeutic target entity per se. > "At least 88...genes regulated by adaptogens were closely associated with adaptive stress-response signaling pathways...including neuronal signaling related to corticotropin-releasing hormone...protein kinase A...CREB; ...CXCR4,...melatonin,...MAPK,...neuroinflammation,...opioids,...renin–angiotensin,...AMPK..." [1] In summary: This entry represents an umbrella concept describing how adaptogenic substances exert pleiotropic effects on many molecular components within the body's integrated network for responding to biological stresses—not a discrete molecule/receptor suitable for structured drug-target mapping[1][2][3].
Adaptogens act by modulating multiple intracellular and extracellular signaling pathways involved in the adaptive stress response. These include activation or regulation of genes and proteins related to corticotropin-releasing hormone signaling, cAMP-mediated protein kinase A/CREB pathway, MAPK pathway, neuroinflammation mediators, G-protein-coupled receptors (GPCRs), nuclear receptors like RORA, transcription factors such as FOS and FOXO6, kinases like MAPK10/MAPK13/PRKCH/ROS1/FLT1/MERTK/TTN[1][2]. They function as mild "stress mimetics," gently stimulating these pathways to improve resilience against physiological or psychological overload[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple targets via adaptogenic modulation of stress response pathways.